Ascendis Pharma
Showing 1 - 25 of 222
Turner Syndrome Trial in United States (Lonapegsomatropin, Somatropin)
Recruiting
- Turner Syndrome
- Lonapegsomatropin
- Somatropin
-
Los Angeles, California
- +17 more
Jan 23, 2023
Achondroplasia Trial in Worldwide (TransCon CNP, Placebo for TransCon CNP, sWfI Placebo for TransCon CNP)
Active, not recruiting
- Achondroplasia
- TransCon CNP
- +2 more
-
Little Rock, Arkansas
- +14 more
Dec 20, 2022
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo
-
San Francisco, California
- +20 more
Aug 5, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8
Recruiting
- Advanced Solid Tumor
- +6 more
- TransCon TLR7/8 Agonist
- Pembrolizumab
-
Duarte, California
- +12 more
Sep 21, 2022
Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (Lonapegsomatropin, Placebo,
Recruiting
- Growth Hormone Deficiency
- +2 more
- Lonapegsomatropin
- +2 more
-
Phoenix, Arizona
- +63 more
Apr 12, 2022
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon IL-2 ß/?,
Recruiting
- Advanced Solid Tumor
- +7 more
- TransCon IL-2 β/γ
- +4 more
-
Boston, Massachusetts
- +7 more
Nov 16, 2022
Hypoparathyroidism, Endocrine System Diseases, Parathyroid Diseases Trial in Worldwide (TransCon PTH, Placebo for TransCon PTH)
Active, not recruiting
- Hypoparathyroidism
- +2 more
- TransCon PTH
- Placebo for TransCon PTH
-
Chicago, Illinois
- +14 more
Mar 2, 2022
Growth Hormone Deficiency, Pediatric, hGH (Human Growth Hormone), Endocrine System Diseases Trial in Worldwide (Once weekly
Completed
- Growth Hormone Deficiency, Pediatric
- +4 more
- Once weekly subcutaneous injection of TransCon hGH
- Once daily subcutaneous injection of Genotropin
-
Birmingham, Alabama
- +52 more
Dec 6, 2021
Achondroplasia Trial in China (TransCon CNP, Placebo for TransCon CNP)
Recruiting
- Achondroplasia
- TransCon CNP
- Placebo for TransCon CNP
-
Beijing, China
- +5 more
Feb 9, 2022
Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)
Active, not recruiting
- Growth Hormone Deficiency, Pediatric
- +3 more
- TransCon hGH
-
Birmingham, Alabama
- +41 more
Oct 13, 2021
Growth Hormone Deficiency Trial in Centennial (No intervention)
Recruiting
- Growth Hormone Deficiency
- No intervention
-
Centennial, ColoradoAscendis Pharma Investigational Site
Apr 18, 2023
Achondroplasia Trial in Parkville (TransCon CNP)
Recruiting
- Achondroplasia
- TransCon CNP
-
Parkville, Victoria, AustraliaAscendis Pharma Investigational Site
Jun 30, 2023
Adult Growth Hormone Deficiency, Endocrine System Diseases, Hormone Deficiency Trial in Las Vegas (Lonapegsomatropin)
Recruiting
- Adult Growth Hormone Deficiency
- +2 more
-
Las Vegas, NevadaAscendis Pharma Investigational Site
Dec 28, 2021
Achondroplasia Trial (Navepegritide, Placebo for Navepegritide)
Not yet recruiting
- Achondroplasia
- Navepegritide
- Placebo for Navepegritide
- (no location specified)
Oct 6, 2023
Hypoparathyroidism Trial (Palopegteriparatide (TransCon PTH))
Available
- Hypoparathyroidism
- Palopegteriparatide (TransCon PTH)
- (no location specified)
Jan 10, 2023
A Prospective, Non-interventional, Long-term, Post-Authorisation
Not yet recruiting
- Growth Hormone Deficiency
- No intervention
- (no location specified)
Mar 8, 2023
Growth Hormone Deficiency, Endocrine System Diseases, Hormones Trial in Wuhan (TransCon hGH, daily hGH)
Unknown status
- Growth Hormone Deficiency
- +4 more
- TransCon hGH
- daily hGH
-
Wuhan, Hubei, ChinaDepartment of Pediatrics, Tongji Hospital, Tongji Medical Colleg
Mar 27, 2020
Achondroplasia Trial (TransCon CNP, Placebo for TransCon CNP)
Not yet recruiting
- Achondroplasia
- TransCon CNP
- Placebo for TransCon CNP
- (no location specified)
Jan 11, 2023
Head and Neck Tumors Trial (TransCon TLR7/8 Agonist, Pembrolizumab, TransCon IL-2 ß/?)
Not yet recruiting
- Head and Neck Neoplasms
- TransCon TLR7/8 Agonist
- +2 more
- (no location specified)
Aug 4, 2023
Growth Hormone Deficiency, Pediatric, Endocrine System Diseases, Hormone Deficiency Trial in Worldwide (TransCon hGH)
Completed
- Growth Hormone Deficiency, Pediatric
- +3 more
- TransCon hGH
-
Birmingham, Alabama
- +23 more
Dec 7, 2021
Healthy Trial in Cairo (Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose), Mirfenacin MR
Completed
- Healthy
- Vesicare (Solifenacin Succinate 5 mg) & Betmiga (Mirabegron 50 mg) (Reference first dose)
- +2 more
-
Cairo, EgyptGenuine Research Center GRC
Mar 2, 2023
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Hypertension, Coronary Artery Disease Trial in Vadodara (Amlodipine Freeze-Dried Powder for Oral Solution 5 mg, Norvasc 5 mg
Active, not recruiting
- Hypertension
- Coronary Artery Disease
- Amlodipine Freeze-Dried Powder for Oral Solution 5 mg
- Norvasc 5 mg tablets of Pfizer Labs
-
Vadodara, Gujarat, IndiaAccutest Research Laboratories (I) Pvt. Ltd.
Apr 10, 2023
Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)
Recruiting
- Glaucoma, Open-Angle
- Ocular Hypertension
- Dorzolamide / Timolol Ophthalmic Solution
- dorzolamide/timolol
-
Olivos, Buenos Aires, Argentina
- +5 more
May 10, 2023
Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))
Completed
- Healthy
- Gleptomet 50/1000(Metformin HCl & Sitagliptin)
- Janumet 50/1000(Metformin HCl & Sitagliptin)
-
Cairo, EgyptGenuine Research Center GRC
Mar 22, 2023